Balance Sheet Cigna

Equities

CI

US1255231003

Managed Healthcare

Real-time Estimate Cboe BZX Other stock markets 20:44:50 22/01/2026 GMT			5-day change	1st Jan Change
280.06 ^USD	+1.88%		+0.40%	+1.39%

06:06pm	UnitedHealth, CVS, Cigna, Elevance CEOs commit to covering vaccines despite changes to US child immunization schedule - committee hearing	RE
03:25pm	US lawmakers press health insurance executives on affordability	RE

761c527d0abb96facbe5cb588c.2XQPLQQnuqOl4HSNMkvbFCNJoKljcvgJOm0e9kx1wF8.rgxld2NEwNvppR3pVS-xRm4w2M8UA6o5ew9NxTxFji68Fmxhbm3QyM2BEw

Published financial data: CIGNA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	159B	173B	179B	194B	246B
Gain (Loss) on Sale of Investment, Total (Rev)	-	-	-	-	-
Interest And Invest. Income (Rev)	1.24B	1.55B	1.16B	1.17B	973M
Total Revenues	160B	174B	181B	195B	247B
Cost of Goods Sold, Total	136B	151B	157B	170B	221B
Gross Profit	24.21B	22.96B	23.48B	25.18B	25.96B
Selling General & Admin Expenses, Total	13.66B	12.81B	13.12B	14.37B	14.57B
Stock-Based Compensation (IS)	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	1.98B	2B	1.88B	1.82B	1.7B
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	15.64B	14.81B	15B	16.19B	16.27B
Operating Income	8.56B	8.16B	8.48B	8.99B	9.69B
Interest Expense, Total	-1.37B	-1.12B	-1.16B	-1.4B	-1.44B
Net Interest Expenses	-1.37B	-1.12B	-1.16B	-1.4B	-1.44B
EBT, Excl. Unusual Items	7.2B	7.04B	7.32B	7.59B	8.26B
Restructuring Charges	-31M	-168M	-22M	-252M	-
Merger & Related Restructuring Charges	-527M	-169M	-135M	-45M	-275M
Gain (Loss) On Sale Of Investments	149M	196M	-495M	-78M	-2.74B
Gain (Loss) On Sale Of Assets	4.2B	-	1.66B	-1.5B	24M
Legal Settlements	-25M	27M	28M	-201M	-
Other Unusual Items	-98M	-141M	-	-	-
EBT, Incl. Unusual Items	10.87B	6.78B	8.35B	5.51B	5.27B
Income Tax Expense	2.38B	1.37B	1.61B	141M	1.49B
Earnings From Continuing Operations	8.49B	5.42B	6.75B	5.37B	3.78B
Net Income to Company	8.49B	5.42B	6.75B	5.37B	3.78B
Minority Interest	-31M	-50M	-78M	-208M	-344M
Net Income - (IS)	8.46B	5.36B	6.67B	5.16B	3.43B
Net Income to Common Incl Extra Items	8.46B	5.36B	6.67B	5.16B	3.43B
Net Income to Common Excl. Extra Items	8.46B	5.36B	6.67B	5.16B	3.43B
Per Share Items
Net EPS - Basic	23.17	15.87	21.54	17.57	12.25
Basic EPS - Continuing Operations	23.17	15.87	21.54	17.57	12.25
Basic Weighted Average Shares Outstanding	365M	338M	310M	294M	280M
Net EPS - Diluted	22.96	15.73	21.3	17.39	12.12
Diluted EPS - Continuing Operations	22.96	15.73	21.3	17.39	12.12
Diluted Weighted Average Shares Outstanding	368M	341M	313M	297M	283M
Normalized Basic EPS	12.24	12.87	14.52	15.43	17.18
Normalized Diluted EPS	12.13	12.75	14.35	15.27	17.01
Dividend Per Share	0.04	4	4.48	4.92	5.6
Payout Ratio	-	25	20.76	28.08	45.63
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	10.37B	9.96B	10.34B	10.8B	11.45B
EBITA	10.09B	9.7B	10.08B	10.54B	11.2B
EBIT	8.56B	8.16B	8.48B	8.99B	9.69B
EBITDAR	10.61B	10.17B	10.5B	10.95B	-
Total Revenues (As Reported)	160B	174B	181B	195B	247B
Effective Tax Rate - (Ratio)	21.89	20.16	19.24	2.56	28.3
Current Domestic Taxes	2.43B	1.38B	1.87B	1.64B	1.34B
Current Foreign Taxes	334M	207M	219M	161M	248M
Total Current Taxes	2.76B	1.59B	2.09B	1.8B	1.59B
Deferred Domestic Taxes	-397M	-289M	-452M	-613M	-159M
Deferred Foreign Taxes	11M	69M	-28M	-1.05B	64M
Total Deferred Taxes	-386M	-220M	-480M	-1.66B	-95M
Normalized Net Income	4.47B	4.35B	4.49B	4.53B	4.82B
Interest on Long-Term Debt	3M	2M	2M	4M	-
Non-Cash Pension Expense	-14M	-55M	-43M	52M	-13M
Supplemental Operating Expense Items
Net Rental Expense, Total	238M	209M	165M	153M	-
Imputed Operating Lease Interest Expense	72.76M	55.17M	46.65M	54.46M	-
Imputed Operating Lease Depreciation	165M	154M	118M	98.54M	-
Stock-Based Comp., SG&A Exp. (Total)	190M	183M	167M	220M	238M
Stock-Based Comp., Other (Total)	99M	85M	97M	66M	70M
Total Stock-Based Compensation	289M	268M	264M	286M	308M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	10.18B	5.08B	5.92B	7.82B	7.55B
Short Term Investments	1.33B	920M	905M	925M	665M
Total Cash And Short Term Investments	11.51B	6B	6.83B	8.75B	8.22B
Accounts Receivable, Total	12B	14.62B	16.97B	17.72B	24.06B
Other Receivables	409M	585M	422M	183M	321M
Total Receivables	12.41B	15.2B	17.39B	17.9B	24.39B
Inventory	3.16B	3.72B	4.78B	5.64B	6.69B
Other Current Assets, Total	713M	11.21B	1.12B	5.05B	9.58B
Total Current Assets	27.8B	36.13B	30.12B	37.35B	48.87B
Gross Property Plant And Equipment	3.27B	3.32B	2.63B	2.65B	2.12B
Accumulated Depreciation	-1.53B	-1.65B	-1.33B	-1.4B	-1.29B
Net Property Plant And Equipment	1.74B	1.66B	1.3B	1.25B	828M
Long-term Investments	24B	18.4B	17.14B	18.14B	15.13B
Goodwill	44.65B	45.81B	45.81B	44.26B	44.37B
Other Intangibles, Total	38.19B	36.61B	35.34B	33.76B	32.24B
Deferred Tax Assets Long-Term	-	-	-	2.29B	954M
Deferred Charges Long-Term	3.38B	677M	-	-	-
Other Long-Term Assets, Total	15.68B	15.6B	14.22B	15.72B	13.49B
Total Assets	155B	155B	144B	153B	156B
Liabilities
Accounts Payable, Total	18.82B	21.96B	24.84B	28.37B	37.76B
Accrued Expenses, Total	6.98B	7.16B	7.89B	9.65B	6.49B
Short-term Borrowings	1.03B	2.03B	-	1.24B	880M
Current Portion of Long-Term Debt	2.33B	495M	2.96B	1.5B	2.11B
Current Portion of Leases	170M	182M	147M	147M	43M
Unearned Revenue Current, Total	485M	-	576M	846M	-
Other Current Liabilities	6.2B	11.74B	4.81B	6.97B	10.7B
Total Current Liabilities	36.02B	43.57B	41.23B	48.72B	57.98B
Long-Term Debt	29.51B	31.1B	28.03B	28.09B	28.9B
Long-Term Leases	527M	464M	412M	406M	41M
Unearned Revenue Non Current	394M	-	22M	22M	31M
Pension & Other Post Retirement Benefits	962M	363M	-	-	-
Deferred Tax Liability Non Current	8.94B	8.35B	7.75B	7.17B	6.98B
Other Non Current Liabilities	28.71B	23.86B	21.53B	22B	20.72B
Total Liabilities	105B	108B	98.98B	106B	115B
Common Stock, Total	4M	4M	4M	4M	4M
Additional Paid In Capital	28.98B	29.57B	30.23B	30.67B	31.29B
Retained Earnings	28.58B	32.59B	37.87B	41.65B	43.52B
Treasury Stock	-6.37B	-14.18B	-21.84B	-24.24B	-31.44B
Comprehensive Income and Other	-861M	-884M	-1.4B	-1.86B	-2.34B
Total Common Equity	50.32B	47.11B	44.87B	46.22B	41.03B
Minority Interest	65M	72M	79M	128M	210M
Total Equity	50.39B	47.18B	44.95B	46.35B	41.24B
Total Liabilities And Equity	155B	155B	144B	153B	156B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	352M	321M	297M	292M	274M
ECS Total Common Shares Outstanding	355M	323M	299M	293M	274M
Book Value / Share	141.84	145.88	150.24	158.03	149.87
Tangible Book Value	-32.52B	-35.31B	-36.28B	-31.79B	-35.58B
Tangible Book Value Per Share	-91.66	-109.33	-121.47	-108.7	-129.95
Total Debt	33.56B	34.26B	31.55B	31.38B	31.97B
Net Debt	22.05B	28.26B	24.72B	22.63B	23.76B
Debt Equivalent of Unfunded Proj. Benefit Obligation	977M	377M	-238M	-204M	-211M
Debt Equivalent Oper. Leases	1.9B	1.67B	1.32B	1.22B	-
Minority Interest, Total (Incl. Fin. Div)	65M	72M	79M	128M	210M
Equity Method Investments, Total	800M	-	900M	200M	-
Account Code - Inventory Valuation	5	5	5	5	5
Full Time Employees	73.7K	73.7K	69.16K	70.32K	71.3K
Part Time Employees	-	-	2.14K	2.18K	2.2K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	1.25B	336M	-	4.53B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	8.46B	5.36B	6.67B	5.16B	3.43B
Depreciation & Amortization - CF	276M	253M	251M	260M	248M
Amortization of Goodwill and Intangible Assets - (CF)	1.53B	1.55B	1.61B	1.55B	1.51B
Depreciation & Amortization, Total	1.8B	1.8B	1.86B	1.81B	1.75B
Amortization of Deferred Charges, Total - (CF)	999M	1.12B	1.08B	1.22B	1.02B
(Gain) Loss From Sale Of Asset	-4.2B	-	-1.66B	1.5B	-24M
(Gain) Loss on Sale of Investments - (CF)	-149M	-196M	495M	78M	2.74B
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-156M	-29M	-402M	-1.45B	249M
Change In Accounts Receivable	-1.5B	-2.84B	-2.24B	-1.66B	-7.37B
Change In Inventories	-504M	-557M	-1.06B	-868M	-1.03B
Change In Accounts Payable	4.24B	1.88B	3.33B	5.51B	9.9B
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	1.36B	644M	578M	508M	-302M
Cash from Operations	10.35B	7.19B	8.66B	11.81B	10.36B
Capital Expenditure	-1.09B	-1.15B	-1.3B	-1.57B	-1.41B
Cash Acquisitions	-139M	-1.83B	-	-447M	-131M
Divestitures	5.59B	-61M	4.84B	13M	521M
Investment in Marketable and Equity Securities, Total	-1.31B	-513M	-209M	-2.9B	-248M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-94M	-147M	-63M	68M	134M
Other Investing Activities, Total	23M	97M	-170M	-332M	-972M
Cash from Investing	2.98B	-3.61B	3.1B	-5.17B	-2.1B
Short Term Debt Issued, Total	1.46B	975M	-	1.2B	-
Long-Term Debt Issued, Total	3.46B	4.26B	-	1.49B	4.46B
Total Debt Issued	4.92B	5.24B	-	2.69B	4.46B
Short Term Debt Repaid, Total	-1.4B	-	-2.06B	-	-402M
Long-Term Debt Repaid, Total	-8.05B	-4.58B	-500M	-2.97B	-3B
Total Debt Repaid	-9.45B	-4.58B	-2.56B	-2.97B	-3.4B
Issuance of Common Stock	376M	326M	389M	187M	305M
Repurchase of Common Stock	-4.04B	-7.74B	-7.61B	-2.28B	-7.03B
Common Dividends Paid	-	-1.34B	-1.38B	-1.45B	-1.57B
Common & Preferred Stock Dividends Paid	-	-1.34B	-1.38B	-1.45B	-1.57B
Other Financing Activities, Total	-343M	-112M	-79M	-469M	-411M
Cash from Financing	-8.53B	-8.21B	-11.24B	-4.29B	-7.65B
Foreign Exchange Rate Adjustments	41M	-65M	-86M	16M	-20M
Miscellaneous Cash Flow Adjustments	-	-425M	-	-467M	-1.34B
Net Change in Cash	4.83B	-5.12B	428M	1.89B	-745M
Supplemental Items
Cash Interest Paid	1.44B	1.25B	1.23B	1.33B	1.34B
Cash Income Tax Paid (Refund)	1.84B	2.24B	1.85B	1.47B	898M
Levered Free Cash Flow	12.54B	960M	10.57B	8.9B	3.79B
Unlevered Free Cash Flow	13.39B	1.66B	11.3B	9.77B	4.69B
Change In Net Working Capital	-6.04B	5.48B	-4.1B	-2.41B	3.05B
Net Debt Issued / Repaid	-4.52B	657M	-2.56B	-278M	1.06B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.44	3.29	3.55	3.79	3.93
Return on Total Capital	6.4	6.16	6.71	7.29	8.05
Return On Equity %	17.73	11.1	14.64	11.79	8.63
Return on Common Equity	17.68	11.01	14.5	11.36	7.87
Margin Analysis
Gross Profit Margin %	15.09	13.19	13	12.89	10.51
SG&A Margin	8.52	7.36	7.27	7.36	5.9
EBITDA Margin %	6.46	5.72	5.73	5.53	4.63
EBITA Margin %	6.29	5.57	5.59	5.4	4.53
EBIT Margin %	5.34	4.69	4.7	4.6	3.92
Income From Continuing Operations Margin %	5.29	3.11	3.74	2.75	1.53
Net Income Margin %	5.27	3.08	3.69	2.64	1.39
Net Avail. For Common Margin %	5.27	3.08	3.69	2.64	1.39
Normalized Net Income Margin	2.78	2.5	2.49	2.32	1.95
Levered Free Cash Flow Margin	7.82	0.55	5.86	4.56	1.53
Unlevered Free Cash Flow Margin	8.35	0.95	6.26	5	1.9
Asset Turnover
Asset Turnover	1.03	1.12	1.21	1.32	1.6
Fixed Assets Turnover	91.76	102.16	121.76	153.27	289.88
Receivables Turnover (Average Receivables)	14.22	12.97	11.36	11.19	11.86
Inventory Turnover (Average Inventory)	46.75	43.88	36.95	32.64	35.85
Short Term Liquidity
Current Ratio	0.77	0.83	0.73	0.77	0.84
Quick Ratio	0.66	0.49	0.59	0.55	0.56
Operating Cash Flow to Current Liabilities	0.29	0.17	0.21	0.24	0.18
Days Sales Outstanding (Average Receivables)	25.73	28.15	32.14	32.62	30.86
Days Outstanding Inventory (Average Inventory)	7.83	8.32	9.88	11.18	10.21
Average Days Payable Outstanding	46.01	49.08	54.03	56.81	54.46
Cash Conversion Cycle (Average Days)	-12.45	-12.61	-12.02	-13	-13.39
Long Term Solvency
Total Debt/Equity	66.61	72.62	70.19	67.69	77.52
Total Debt / Total Capital	39.98	42.07	41.24	40.37	43.67
LT Debt/Equity	59.61	66.89	63.28	61.48	70.16
Long-Term Debt / Total Capital	35.78	38.75	37.18	36.66	39.52
Total Liabilities / Total Assets	67.59	69.54	68.77	69.66	73.54
EBIT / Interest Expense	6.26	7.29	7.29	6.42	6.75
EBITDA / Interest Expense	7.75	9.08	9.03	7.82	7.98
(EBITDA - Capex) / Interest Expense	6.95	8.05	7.91	6.7	7
Total Debt / EBITDA	3.16	3.37	3.01	2.86	2.79
Net Debt / EBITDA	2.08	2.78	2.35	2.07	2.08
Total Debt / (EBITDA - Capex)	3.53	3.8	3.43	3.34	3.18
Net Debt / (EBITDA - Capex)	2.32	3.14	2.69	2.41	2.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.45	8.53	3.7	8.17	26.56
Gross Profit, 1 Yr. Growth %	-3.48	-5.14	2.23	7.14	3.13
EBITDA, 1 Yr. Growth %	-10.48	-3.96	3.8	4.14	5.53
EBITA, 1 Yr. Growth %	-10.67	-3.84	3.92	4.15	5.78
EBIT, 1 Yr. Growth %	-2.84	-4.78	3.95	5.57	7.28
Earnings From Cont. Operations, 1 Yr. Growth %	65.8	-36.21	24.58	-20.79	-29.67
Net Income, 1 Yr. Growth %	65.71	-36.57	24.29	-22.97	-33.5
Normalized Net Income, 1 Yr. Growth %	-0.45	-2.66	3.35	0.4	6.22
Diluted EPS Before Extra, 1 Yr. Growth %	70.83	-31.49	35.41	-18.78	-30.3
Accounts Receivable, 1 Yr. Growth %	15.58	21.8	16.11	4.43	37.91
Inventory, 1 Yr. Growth %	18.94	17.6	28.34	18.17	18.55
Net Property, Plant and Equip., 1 Yr. Growth %	-0.46	-4.59	-21.82	-4.15	-5.59
Total Assets, 1 Yr. Growth %	-0.21	-0.36	-7.07	6.17	2.04
Tangible Book Value, 1 Yr. Growth %	-16.68	8.57	1.88	-12.84	12.18
Common Equity, 1 Yr. Growth %	10.99	-6.38	-4.75	3.46	-11.23
Cash From Operations, 1 Yr. Growth %	9.12	-30.52	20.37	36.47	-12.27
Capital Expenditures, 1 Yr. Growth %	4.19	5.48	12.22	21.47	-10.62
Levered Free Cash Flow, 1 Yr. Growth %	296.45	-92.34	1K	-15.99	-57.9
Unlevered Free Cash Flow, 1 Yr. Growth %	221.26	-87.61	580.97	-13.65	-52.69
Dividend Per Share, 1 Yr. Growth %	0	9.9K	12	9.82	13.82
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	81.58	6.47	6.09	5.91	17
Gross Profit, 2 Yr. CAGR %	21.76	-4.31	-1.52	4.74	5.11
EBITDA, 2 Yr. CAGR %	40.93	-7.28	-0.16	4.12	4.73
EBITA, 2 Yr. CAGR %	41.03	-7.32	-0.04	4.19	4.86
EBIT, 2 Yr. CAGR %	32.7	-3.81	-0.51	4.94	6.29
Earnings From Cont. Operations, 2 Yr. CAGR %	79.12	2.84	-10.86	-0.44	-25.36
Net Income, 2 Yr. CAGR %	79.09	2.52	-11.21	-1.94	-28.43
Normalized Net Income, 2 Yr. CAGR %	24.01	-1.56	0.3	2.08	3.27
Diluted EPS Before Extra, 2 Yr. CAGR %	47.59	8.18	-3.68	5.08	-24.76
Accounts Receivable, 2 Yr. CAGR %	8.48	18.65	18.92	10.12	19.08
Inventory, 2 Yr. CAGR %	5.92	18.27	22.85	23.15	18.36
Net Property, Plant and Equip., 2 Yr. CAGR %	16.59	-2.54	-13.63	-13.43	-20.22
Total Assets, 2 Yr. CAGR %	0.72	-0.28	-3.78	-0.69	4.09
Tangible Book Value, 2 Yr. CAGR %	-15.7	-4.89	5.62	-5.51	-1.24
Common Equity, 2 Yr. CAGR %	10.75	1.94	-5.57	-0.95	-4.16
Cash From Operations, 2 Yr. CAGR %	65.69	-12.93	-8.55	28.17	9.42
Capital Expenditures, 2 Yr. CAGR %	43.94	4.84	8.8	16.75	4.2
Levered Free Cash Flow, 2 Yr. CAGR %	6.25	-44.9	-8.16	203.83	-40.18
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.19	-36.9	-8.14	142.4	-35.76
Dividend Per Share, 2 Yr. CAGR %	0	900	958.3	10.91	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	56.55	52.95	5.54	6.78	12.39
Gross Profit, 3 Yr. CAGR %	19.78	12.04	-2.18	1.32	4.2
EBITDA, 3 Yr. CAGR %	33.31	24.02	-3.73	1.37	4.73
EBITA, 3 Yr. CAGR %	33.7	24.13	-3.72	1.46	4.87
EBIT, 3 Yr. CAGR %	27.57	18.8	-1.29	1.62	5.89
Earnings From Cont. Operations, 3 Yr. CAGR %	56.09	26.96	9.63	-14.15	-11.33
Net Income, 3 Yr. CAGR %	55.79	26.71	9.32	-15.17	-13.85
Normalized Net Income, 3 Yr. CAGR %	21.83	14.39	0.05	0.5	3.44
Diluted EPS Before Extra, 3 Yr. CAGR %	37.82	14.28	16.59	-8.85	-8.36
Accounts Receivable, 3 Yr. CAGR %	60.47	12.75	17.8	13.88	18.09
Inventory, 3 Yr. CAGR %	140.33	9.68	21.54	21.27	21.6
Net Property, Plant and Equip., 3 Yr. CAGR %	32.13	9.05	-9.44	-10.58	-20.76
Total Assets, 3 Yr. CAGR %	36.03	0.36	-2.6	-0.58	0.21
Tangible Book Value, 3 Yr. CAGR %	71.96	-8.28	-2.4	-0.75	-0.03
Common Equity, 3 Yr. CAGR %	54.25	4.72	-0.34	-2.79	-4.5
Cash From Operations, 3 Yr. CAGR %	36.32	24.02	-3	4.51	12.95
Capital Expenditures, 3 Yr. CAGR %	32.43	29.77	7.24	12.87	6.81
Levered Free Cash Flow, 3 Yr. CAGR %	4.85	-55.78	49.54	-10.8	57.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.81	-47.13	39.44	-9.97	41.24
Dividend Per Share, 3 Yr. CAGR %	0	364.16	382.03	397.32	11.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	33.47	34.3	33.98	32.04	9.98
Gross Profit, 5 Yr. CAGR %	14.22	12	10.75	9.05	0.7
EBITDA, 5 Yr. CAGR %	22.26	22.98	18.75	15.65	-0.24
EBITA, 5 Yr. CAGR %	22.66	23.48	19.02	15.74	-0.18
EBIT, 5 Yr. CAGR %	19.65	20.19	15.49	13.07	1.92
Earnings From Cont. Operations, 5 Yr. CAGR %	32.52	24.06	24.76	15.22	-5.9
Net Income, 5 Yr. CAGR %	32.21	23.51	24.41	14.39	-7.62
Normalized Net Income, 5 Yr. CAGR %	15.22	18.22	12.71	9.32	1.43
Diluted EPS Before Extra, 5 Yr. CAGR %	23.35	16.95	19.42	10.53	-2.05
Accounts Receivable, 5 Yr. CAGR %	27.51	37.03	42.34	11.69	18.31
Inventory, 5 Yr. CAGR %	-	-	83.76	14.88	20.25
Net Property, Plant and Equip., 5 Yr. CAGR %	16.87	16.75	11.47	-0.57	-13.92
Total Assets, 5 Yr. CAGR %	22.18	21.14	18.44	-0.06	0.01
Tangible Book Value, 5 Yr. CAGR %	47.15	40.06	41.5	-7.02	-1.83
Common Equity, 5 Yr. CAGR %	33.13	27.98	26.76	2.41	-1.98
Cash From Operations, 5 Yr. CAGR %	28.68	12.3	16.2	25.66	1.79
Capital Expenditures, 5 Yr. CAGR %	16.49	20.14	22.42	24.4	6.01
Levered Free Cash Flow, 5 Yr. CAGR %	63.99	-31.38	-0.56	-4.34	3.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	66.16	-23.86	0.56	-2.74	2.37
Dividend Per Share, 5 Yr. CAGR %	0	151.19	156.95	161.81	168.67